Effect of treatment with L-phenylalanine mustard and antibody on survival time of mice with intracerebral ependymoblastomas.
D000818:Animals; D000906:Antibodies / Q000008:administration & dosage*; D001932:Brain Neoplasms / Q000628:therapy*; D004806:Ependymoma / Q000628:therapy*; D007167:Immunotherapy; D051379:Mice; D008809:Mice, Inbred C3H; D009150:Mustard Compounds / Q000627:therapeutic use*; D010649:Phenylalanine / Q000627:therapeutic use*
D000906:Antibodies; D009150:Mustard Compounds; D010649:Phenylalanine